TRENDING

‘Dominance Over for Egypt, Nigeria’, Says Saleh • WORLD CUP 2026: Separating Tax Facts from Social Media Fiction • FIFA Scraps $20b World Cup Sell-off Plan • Bestseller, Children of Blood and Bone, Brings Magical Land of ‘Orisha’ to Life • MTN Foundation Marks 20 Years of MUSON Partnership, Graduates 39 Music Scholars • FIFA drops plan to sell World Cup stake after boycott threat • Controversy Trails Tyla’s Upcoming Lagos Concert • Soso Soberekon Quits Bachelorhood in Grand Style • Maja completes Le Havre move • Nigeria’s Youth Explosion: Harnessing the Demographic Dividend • ‘Protest Over’ (Phrasal Verb) Wrong • Jumoke Oduwole: Moving FMITI from Policy Promises to Measurable Outcomes • Of Tyla and the Country We Helped Save • Lookman, Boniface lead market value slide • Epidemic fears loom as refuse mounds overrun Lagos streets, markets • Global mistrust hurting business, trade — Okonjo-Iweala • 27 farmer-herder conflict alerts recorded in Katsina, Zamfara – Report • Promoting Igbo Culture • St. Ange to X-Ray Global Tourism at Clevenard Open Project 2026 • Cybersecurity: Trusted Access, Data Sovereignty and Nigeria’s Defining Moment • ‘Dominance Over for Egypt, Nigeria’, Says Saleh • WORLD CUP 2026: Separating Tax Facts from Social Media Fiction • FIFA Scraps $20b World Cup Sell-off Plan • Bestseller, Children of Blood and Bone, Brings Magical Land of ‘Orisha’ to Life • MTN Foundation Marks 20 Years of MUSON Partnership, Graduates 39 Music Scholars • FIFA drops plan to sell World Cup stake after boycott threat • Controversy Trails Tyla’s Upcoming Lagos Concert • Soso Soberekon Quits Bachelorhood in Grand Style • Maja completes Le Havre move • Nigeria’s Youth Explosion: Harnessing the Demographic Dividend • ‘Protest Over’ (Phrasal Verb) Wrong • Jumoke Oduwole: Moving FMITI from Policy Promises to Measurable Outcomes • Of Tyla and the Country We Helped Save • Lookman, Boniface lead market value slide • Epidemic fears loom as refuse mounds overrun Lagos streets, markets • Global mistrust hurting business, trade — Okonjo-Iweala • 27 farmer-herder conflict alerts recorded in Katsina, Zamfara – Report • Promoting Igbo Culture • St. Ange to X-Ray Global Tourism at Clevenard Open Project 2026 • Cybersecurity: Trusted Access, Data Sovereignty and Nigeria’s Defining Moment

August 1, 2026|01:06

Back to Home

Hot Topics

SCD & gene therapy: Who is it for?

Punch Nigeria about 2 hours 1 mins read

Explore gene therapy for Sickle Cell Disease and other inherited illnesses. Understand who can benefit from this revolutionary treatment and its challenges Read More: https://punchng.com/scd-gene-therapy-who-is-it-for/

This article was sourced from an external publication.

Share this article